What a role map is not
A role map is orientation — not a job description, a competency framework, or a statement of what any employer expects of you.
You are responsible for the quality of the ingredients that carry a medicine — the fillers, coatings and stabilisers — which are often made on equipment shared with industrial products.
You operate to the Joint IPEC-PQG Good Manufacturing Practices Guide for Pharmaceutical Excipients (v5, 2022), release against Ph. Eur. and USP-NF monographs, and support customers’ excipient risk assessments under the EU guideline on formalised risk assessment for ascertaining the appropriate GMP for excipients (2015/C 95/02). Change notification to customers is a contractual and quality obligation, not a courtesy.
An excipient plant is usually a chemical plant with a pharmaceutical customer, and the quality system has to bridge that gap honestly rather than claim a GMP posture the site does not hold.
YOUR NEIGHBOURHOOD, IN ONE CONNECTED SYSTEM
At the upstream edge of the pharmaceutical supply chain, where a chemical manufacturing operation meets a medicinal product’s quality requirements.
- Chemical process design and the site’s own operating standards
- Customer incoming inspection and their excipient risk assessment
- Formulation and manufacture of the finished product
- Production for consistent process control across shared equipment
- Laboratory for compendial testing and method suitability
- Sales and technical service for accurate customer specifications
- Formulators whose product performance depends on excipient functionality
- Customer quality units performing supplier qualification and risk assessment
- Patients, through variability the finished-product test may not detect
- Release of excipient lots against the agreed specification and monograph
- Change notification to customers before a change is implemented
- The honest statement of what GMP standard the site actually operates to
- The customer’s excipient risk assessment or their formulation
- The finished medicinal product’s quality decisions
- The compendial monograph itself
- Site management, where a process change would affect a functional property customers rely on
- Customers directly, where a released lot is later found to deviate
- Certificates of analysis against monograph and functional specifications
- Change-notification records and customer acknowledgements
- Supplier-audit responses and the site’s excipient GMP self-assessment
WHAT THIS ROLE CAN EVIDENCE · 0
No published competency maps to Excipient Quality Manager yet. 14 are published across the registry, and this role is not among the ones they name.
Read the standard and its stated coverage →A role map is Locate, moment 2 of 5: what surrounds your work, what you own, and what you escalate. It does not teach the practice or test it. Next is Learn — the Quality Assurance pathway. No scenario exercises this role yet, so Practise comes later for it, then what any of it evidences. Skip any of them — the order does not change.
The regulations and standards this pathway anchors on. SPEQ decodes and cites each one; the authoritative text lives at the official source.
- 21 CFR Part 211Current Good Manufacturing Practice for Finished PharmaceuticalsFDA · last revised 2023-04-01
- ICH Q9(R1)Quality Risk ManagementICH · last revised 2023-01-18
- ICH Q10Pharmaceutical Quality SystemICH · last revised 2008-06-01
- ISO 9001:2015Quality Management Systems — RequirementsISO · last revised 2015-09-15